SCHEMBL30775562

SCHEMBL30775562

Nc1ncnc2ccc(N3CCNCC3)cc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 1/20 0.76
MAP4K4 O95819 6/20 0.74
HTT P42858 1/20 0.51
TGFBR1 P36897 3/20 0.45
ACVR1 Q04771 3/20 0.45
CYP1A2 P05177 6/20 0.44
CYP3A4 P08684 6/20 0.44
CYP2C19 P33261 4/20 0.44
CYP2D6 P10635 3/20 0.44
CLK4 Q9HAZ1 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
USP2 O75604 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ADRB1 P08588 2/20 0.44
HTR2C P28335 1/20 0.43
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30575860 0.99 IP6K1 (0.74) IP6K1MAP4K4HTTTGFBR1ACVR1
SCHEMBL14487035 0.86 IP6K1 (1.00) IP6K1MAP4K4MAPT
SCHEMBL5137752 0.85 MAP4K4 (1.00) IP6K1MAP4K4HTTALDH1A1MAPT
SCHEMBL10968370 0.82 IP6K1 (0.76) IP6K1MAP4K4HTTCYP1A2CYP3A4
SCHEMBL30576156 0.81 IP6K1 (0.61) IP6K1MAP4K4MAPT
Hydrochloric Acid SCHEMBL30576101 0.80 IP6K1 (0.60) IP6K1MAP4K4MAPT
SCHEMBL14537161 0.77 IP6K1 (0.59) IP6K1MAP4K4
Hydrochloric Acid SCHEMBL30575936 0.77 IP6K1 (0.52) IP6K1MAP4K4
SCHEMBL30104253 0.77 HTR3E (0.50) IP6K1MAP4K4TGFBR1ACVR1MAPT
SCHEMBL30478684 0.74 IP6K1 (0.71) IP6K1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117500803-A Amino-substituted heterocycles for the treatment of cancers with EGFR mutations 纽威伦特公司 2024-02-02 CN disclosed